Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
16.56
+1.04 (6.70%)
At close: May 16, 2025, 4:00 PM
16.26
-0.30 (-1.81%)
After-hours: May 16, 2025, 7:23 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $425.40 million as of May 16, 2025. Its market cap has increased by 5.58% in one year.
Market Cap
425.40M
Enterprise Value
176.29M
1-Year Change
5.58%
Ranking
Category
Stock Price
$16.56
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $425.40M, an increase of 91.91%. That is a compound annual growth rate of 51.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 425.40M | -18.20% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.93B |
| Johnson & Johnson | 355.67B |
| AbbVie | 328.04B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 291.37B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |